(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays)By Nancy LapidAug 19 (Reuters) - We also share data
By Nancy LapidAug 14 (Reuters) - We also report on a flavoring chemical in e-cigarettes that damages human embryo cells in lab experiments. BLOOD TEST MAY FIND PRE-CANCERO
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays)By Nancy LapidAug 26 (Reuters) - We also cover a met
Novartis has announced that the FDA has approved Tafinlar (dabrafenib) in combination with Mekinist (trametinib) for the adjuvant treatment of...
Actelion Pharmaceuticals announced the submission of a supplemental New Drug Application (sNDA) to the FDA seeking to expand the indication...
Pfizer has notified Pain Therapeutics that it has decided to discontinue its agreement to develop and commercialize Remoxy (oxycodone) Extended-Release...
On 23 October 2014, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...
For chemotherapy-naïve patients, enzalutamide demonstrated a significant impact on overall survival compared to placebo
The FDA has accepted the filing of a New Drug Application (NDA) for Jardiance (empagliflozin) plus immediate-release metformin hydrochloride fixed-dose...
Sanofi and Regeneron Pharmaceuticals, Inc announced that the first patients have been dosed in a Phase III clinical study of...